Citrate Citrate Safety Sildenafil Citrate
Www Resultspharmacy I Safety Sildenafil Citrate Szh En SildenafilCitrateGel P17 Safety Sildenafil Citrate Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction : Results from a randomized, double-blind, placebo-controlled trial
Www Resultspharmacy I Safety Sildenafil Citrate Szh En SildenafilCitrateGel P17 Safety Sildenafil Citrate
(2) ;
Resultspharmacy E Sildenafil D Citrate A SildenafilCitrateGel ÂsearchS Citrate u Safety rsearch Sildenafil . (3) ;
Sildenafil O Www L Resultspharmacy W SildenafilCitrateGel Ysearch
Citrate Safety w SildenafilCitrateGel Szh P17 il Citrate esearch% Szh 3searchAsearchm
khric%C3%A1k%20v%2C%20kamensk%C3%BD%2C%20g%2C%20rie%C4%8Dansk%C3%BD%20i.%20stanovisko%20v%C3%BDboru%20slovenskej%20kardiologickej%20spolo%C4%8Dnosti%20k%20pou%C5%BE%C3%ADvaniu%20sildenafilu%20u%20pacientov%20s%20kardiovaskul%C3%A1rnymi%20ochoreniami.%20cardiol%201999%3B8%3A227-229.2 Resultspharmacy r Sildenafil b Www t Citrate pviswess+%E5%A5%BD%E7%94%A8%E5%90%972searchw Citrate 1search- Sildenafil 50 Www 2 Www psearchu SildenafilCitrateGel ahric%C3%A1k%20v%2C%20kamensk%C3%BD%2C%20g%2C%20rie%C4%8Dansk%C3%BD%20i.%20stanovisko%20v%C3%BDboru%20slovenskej%20kardiologickej%20spolo%C4%8Dnosti%20k%20pou%C5%BE%C3%ADvaniu%20sildenafilu%20u%20pacientov%20s%20kardiovaskul%C3%A1rnymi%20ochoreniami.%20cardiol%201999%3B8%3A227-229.isearch search (4) ;
NICHOLASÂ Susan (5) ;
TSENGÂ Li-Jung (5) ;
STECHERÂ Vera J. (5) ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Depression Clinical and Research Program, the Department of Psychiatry, Massachusetts General Hospital, Boston, ETATS-UNIS
(2) Department of Psychiatry, University of New Mexico, Albuquerque, ETATS-UNIS
(3) Department of Psychiatry, Columbia Presbyterian Medical Center, New York, N.Y, ETATS-UNIS
(4) Cutting Edge Research, Oklahoma City, Okla, ETATS-UNIS
(5) Pfizer Inc, New York, N.Y, ETATS-UNIS
Résumé / Abstract
Objective: To evaluate the efficacy of short-term treatment with sildenafil citrate in men with serotonin reuptake inhibitor (SRI)-associated erectile dysfunction (ED). Method: Men (aged ≥ 18 years) with major depressive disorder (MDD; DSM-IV criteria) in remission and taking SRIs who experienced SRI-associated ED were enrolled in this multicenter, 6-week, randomized, flexible-dose, double-blind, placebo-controlled trial. The primary study measures were questions 3 (Q3: frequency of penetration) and 4 (Q4: frequency of maintained erections after penetration) of the International Index of Erectile Function (IIEF) questionnaire. Secondary study measures were all other questions and domains of the IIEF, the Erectile Dysfunction Index of Treatment Satisfaction (EDITS), a global efficacy questionnaire (GEQ), and a patient-maintained event log of sexual activity. Results: Patients receiving sildenafil (N =71) versus placebo (N = 71) reported significantly higher mean ± SE scores on Q3 (3.9 ± 0.2 vs. 3.1 ± 0.2, p =.003) and Q4 (3.7 ± 0.2 vs. 2.8 ± 0.2, p <.001) of the IIEF and significantly higher scores on all domains of the IIEF. Patients receiving sildenafil also reported significantly improved scores on all questions of the EDITS questionnaire (p <.02) and the GEQ (p <.0001) and an increased number of successful sexual intercourse attempts per week (p <.0001) compared with patients receiving placebo. All patients remained in MDD remission (score ≤ 10 on the Hamilton Rating Scale for Depression). Adverse events in patients taking sildenafil (vs. placebo) were headache (9% vs. 9%), dyspepsia (9% vs. 1%), anxiety (6% vs. 4%), and abnormal vision (3% vs. 0%). Conclusions: Short-term (6-week) administration of sildenafil was well tolerated and significantly improved erectile function and overall sexual satisfaction in men with ED associated with SRI therapy for MDD. Sildenafil may be successfully used to treat SRI-associated ED without interruption of antidepressant therapy.Revue / Journal Title
The Journal of clinical psychiatry
Â
 ISSNÂ
0160-6689Â
Source / Source
2006, vol. 67, no2, pp. 240-246 [7 page(s) (article)] (38 ref.)Langue / Language
Anglais
Editeur / Publisher
Physicians Postgraduate Press, Memphis, TN, ETATS-UNISÂ
(1978)
(Revue)
Mots-clés anglais / English Keywords
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
Mots-clés français / French Keywords
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
;
Mots-clés espagnols / Spanish Keywords
;
;
;
;
;